SCHEMBL2409381

SCHEMBL2409381

Cc1ccc2[nH]c(C(=O)NC(C)c3cccc(C(=O)NO)c3)c(C)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
RAB9A P51151 1/20 0.44
ALDH1A1 P00352 2/20 0.43
IMPDH2 P12268 2/20 0.42
RCE1 Q9Y256 1/20 0.41
GPR139 Q6DWJ6 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
GFER P55789 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MLKL Q8NB16 1/20 0.40
EGFR P00533 1/20 0.40
NPC1 O15118 1/20 0.40
MAPK1 P28482 1/20 0.39
HDAC3 O15379 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2408913 0.80 TP53 (0.50) HDAC8HDAC6MEN1KMT2ARAB9A
SCHEMBL12279819 0.78 ALDH1A1 (0.57) HDAC8HDAC6ALDH1A1GPR139NPC1
SCHEMBL2438985 0.78 ALDH1A1 (0.48) HDAC8HDAC6ALDH1A1IMPDH2GPR139
SCHEMBL2413435 0.77 HDAC1 (0.43) HDAC8HDAC6MEN1KMT2ARAB9A
SCHEMBL17149687 0.74 GAA (0.56) MEN1KMT2AIMPDH2RCE1RXFP1
SCHEMBL17149772 0.74 GAA (0.56) MEN1KMT2AIMPDH2RCE1RXFP1
SCHEMBL6919150 0.73 ALDH1A1 (0.48) HDAC8HDAC6ALDH1A1GPR139RXFP1
SCHEMBL2407320 0.72 ALDH1A1 (0.47) HDAC8HDAC6ALDH1A1IMPDH2GPR139
SCHEMBL30300667 0.71 KMT2A (0.54) MEN1KMT2ARAB9AALDH1A1IMPDH2
SCHEMBL14158444 0.71 KMT2A (0.54) MEN1KMT2ARAB9AALDH1A1IMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9382197-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2016-07-05 US disclosed
US-9382197-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2016-07-05 US disclosed
US-20140275093-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-09-18 US disclosed
US-20140275093-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-09-18 US disclosed
WO-2011106632-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 WO disclosed
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 US disclosed
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275093-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC10, HDAC1 HDAC8 15/4885HDAC6 1/4885MEN1 3689/4885
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC10, HDAC1 HDAC8 15/4885HDAC6 1/4885MEN1 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.